-
1 Comment
Opsens Inc is currently in a long term uptrend where the price is trading 35.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Technology sector with a price to sales ratio of 5.3.
Opsens Inc's total revenue rose by 19.3% to $8M since the same quarter in the previous year.
Its net income has increased by 131.8% to $594K since the same quarter in the previous year.
Finally, its free cash flow grew by 201.7% to $1M since the same quarter in the previous year.
Based on the above factors, Opsens Inc gets an overall score of 5/5.
Exchange | TO |
---|---|
CurrencyCode | CAD |
ISIN | CA6838231083 |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Market Cap | 335M |
---|---|
PE Ratio | None |
Target Price | 3.36 |
Dividend Yield | 0.0% |
Beta | 0.32 |
Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada. As of December 12, 2023, Opsens Inc. operates as a subsidiary of Haemonetics Corporation.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for OPS.TO using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025